A detailed history of Franklin Resources Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 59,164 shares of CPRX stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,164
Previous 57,197 3.44%
Holding current value
$1.25 Million
Previous $885,000 32.88%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.19 - $21.35 $29,878 - $41,995
1,967 Added 3.44%
59,164 $1.18 Million
Q2 2024

Aug 14, 2024

SELL
$14.68 - $16.92 $2.48 Million - $2.86 Million
-168,859 Reduced 74.7%
57,197 $885,000
Q1 2024

May 13, 2024

BUY
$13.18 - $17.11 $528,952 - $686,675
40,133 Added 21.59%
226,056 $3.6 Million
Q4 2023

Feb 09, 2024

BUY
$11.78 - $17.29 $393,416 - $577,434
33,397 Added 21.9%
185,923 $3.13 Million
Q3 2023

Nov 13, 2023

BUY
$11.69 - $15.02 $331,142 - $425,471
28,327 Added 22.81%
152,526 $1.78 Million
Q2 2023

Aug 11, 2023

BUY
$11.5 - $18.08 $227,355 - $357,441
19,770 Added 18.93%
124,199 $1.67 Million
Q1 2023

May 12, 2023

BUY
$14.34 - $21.05 $5,649 - $8,293
394 Added 0.38%
104,429 $1.73 Million
Q4 2022

Feb 10, 2023

SELL
$12.25 - $19.5 $391,179 - $622,693
-31,933 Reduced 23.49%
104,035 $1.94 Million
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $2,696 - $5,928
-382 Reduced 0.28%
135,968 $1.74 Million
Q2 2022

Aug 11, 2022

BUY
$6.23 - $8.57 $524,952 - $722,125
84,262 Added 161.77%
136,350 $956,000
Q1 2022

May 13, 2022

BUY
$5.31 - $8.31 $276,587 - $432,851
52,088 New
52,088 $432,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.17B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.